Back to Search Start Over

Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye

Authors :
Iain Gardner
Anam Fayyaz
Kati-Sisko Vellonen
Veli-Pekka Ranta
Mika Reinisalo
Arto Urtti
Giuseppe D'Amico Ricci
Elisa Toropainen
Marika Ruponen
Jooseppi Puranen
Masoud Jamei
Emma M. Heikkinen
Eva M. del Amo
Annika Valtari
Drug Research Program
Drug Delivery
Drug Delivery Unit
Division of Pharmaceutical Biosciences
Source :
European Journal of Pharmaceutics and Biopharmaceutics
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Quantitative understanding of pharmacokinetics of topically applied ocular drugs requires more research to further understanding and to eventually allow predictive in silico models to be developed. To this end, a topical cocktail of betaxolol, timolol and atenolol was instilled on albino rabbit eyes. Tear fluid, corneal epithelium, corneal stroma with endothelium, bulbar conjunctiva, anterior sclera, iris-ciliary body, lens and vitreous samples were collected and analysed using LC-MS/MS. Iris-ciliary body was also analysed after intracameral cocktail injection. Non-compartmental analysis was utilized to estimate the pharmacokinetics parameters. The most lipophilic drug, betaxolol, presented the highest exposure in all tissues except for tear fluid after topical administration, followed by timolol and atenolol. For all drugs, iris-ciliary body concentrations were higher than that of the aqueous humor. After topical instillation the most hydrophilic drug, atenolol, had 3.7 times higher AUCiris-ciliary body than AUCaqueous humor, whereas the difference was 1.4 and 1.6 times for timolol and betaxolol, respectively. This suggests that the non-corneal route (conjunctival-scleral) was dominating the absorption of atenolol, while the corneal route was more important for timolol and betaxolol. The presented data increase understanding of ocular pharmacokinetics of a cocktail of drugs and provide data that can be used for quantitative modeling and simulation.

Details

ISSN :
09396411
Volume :
166
Database :
OpenAIRE
Journal :
European Journal of Pharmaceutics and Biopharmaceutics
Accession number :
edsair.doi.dedup.....071106857dbd82f3ec50430483a317c2
Full Text :
https://doi.org/10.1016/j.ejpb.2021.06.003